E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/28/2009 in the Prospect News Special Situations Daily.

Fosun buys additional Tongjitang Chinese Medicines ADSs

By Jennifer Chiou

New York, Jan. 28 - Tongjitang Chinese Medicines Co. investor Fosun Industrial Co., Ltd. purchased 376,550 American Depositary Shares, representing 1,506,200 of the company's ordinary shares, from Jan. 7 to Jan. 26 at prices between $2.4999 and $2.6500 each, according to a schedule 13D/A filed with the Securities and Exchange Commission.

In a prior SEC filing, Fosun reported the purchase of 471,250 ADSs, representing 1,885,000 of the company's ordinary shares, on Dec. 31 for $2.7844 each.

Fosun now beneficially owns 4,459,078 ADSs, each representing four ordinary shares.

Tongjitang is specialty pharmaceutical company located in Shenzhen, China.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.